Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy J Robinson

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 9, 2021
Patterns and Predictors of Failure in Recurrent or Refractory Large B-Cell Lymphomas After Chimeric Antigen Receptor T-Cell TherapyNicholas B Figura, Timothy J Robinson, Austin J Sim, et al.
International Journal of Radiation Oncology, Biology, Physics|June 9, 2019
Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell LymphomaAustin J Sim, Michael D Jain, Nicholas B Figura, et al.
BMC Cancer|March 5, 2021
Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastasesMatthew N Mills, Chelsea Walker, Chetna Thawani, et al.
Journal of Neuro-Oncology|August 11, 2019
CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastasesNicholas B Figura, Thrisha K Potluri, Homan Mohammadi, et al.
Journal of Neurosurgery|January 22, 2023
Clinical outcomes of non-small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune checkpoint inhibitors, EGFR tyrosine kinase inhibitors, chemotherapy and immune checkpoint inhibitors, or chemotherapy aloneAmmoren E Dohm, Joseph D Tang, Matthew N Mills, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 2026
CAR T-Cell Therapy for Cancer: Updates and Challenges for Response AssessmentDorine de Jong, Jeremy P McGale, Timothy J Robinson, et al.
Journal of Neuro-Oncology|March 20, 2021
Breast cancer subtype predicts clinical outcomes after stereotactic radiation for brain metastasesMatthew N Mills, Chetna Thawani, Nicholas B Figura, et al.
Breast Cancer Research and Treatment|March 13, 2019
Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapyNicholas B Figura, Victoria T Rizk, Homan Mohammadi, et al.
American Journal of Hematology|June 10, 2025
Phase II Trial of Reduced-Intensity Fludarabine, Melphalan, and Total Body Irradiation Conditioning With Haploidentical Donor Peripheral Blood Stem Cell TransplantHany Elmariah, Jongphil Kim, Rebecca Gonzalez, et al.
BMC Cancer|May 16, 2021
Capecitabine and stereotactic radiation in the management of breast cancer brain metastasesMatthew N Mills, Afrin Naz, Chetna Thawani, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
International Journal of Radiation Oncology, Biology, Physics|July 9, 2021
Patterns and Predictors of Failure in Recurrent or Refractory Large B-Cell Lymphomas After Chimeric Antigen Receptor T-Cell TherapyNicholas B Figura, Timothy J Robinson, Austin J Sim, et al.
International Journal of Radiation Oncology, Biology, Physics|June 9, 2019
Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell LymphomaAustin J Sim, Michael D Jain, Nicholas B Figura, et al.
BMC Cancer|March 5, 2021
Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastasesMatthew N Mills, Chelsea Walker, Chetna Thawani, et al.
Journal of Neuro-Oncology|August 11, 2019
CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastasesNicholas B Figura, Thrisha K Potluri, Homan Mohammadi, et al.
Journal of Neurosurgery|January 22, 2023
Clinical outcomes of non-small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune checkpoint inhibitors, EGFR tyrosine kinase inhibitors, chemotherapy and immune checkpoint inhibitors, or chemotherapy aloneAmmoren E Dohm, Joseph D Tang, Matthew N Mills, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 2026
CAR T-Cell Therapy for Cancer: Updates and Challenges for Response AssessmentDorine de Jong, Jeremy P McGale, Timothy J Robinson, et al.
Journal of Neuro-Oncology|March 20, 2021
Breast cancer subtype predicts clinical outcomes after stereotactic radiation for brain metastasesMatthew N Mills, Chetna Thawani, Nicholas B Figura, et al.
Breast Cancer Research and Treatment|March 13, 2019
Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapyNicholas B Figura, Victoria T Rizk, Homan Mohammadi, et al.
American Journal of Hematology|June 10, 2025
Phase II Trial of Reduced-Intensity Fludarabine, Melphalan, and Total Body Irradiation Conditioning With Haploidentical Donor Peripheral Blood Stem Cell TransplantHany Elmariah, Jongphil Kim, Rebecca Gonzalez, et al.
BMC Cancer|May 16, 2021
Capecitabine and stereotactic radiation in the management of breast cancer brain metastasesMatthew N Mills, Afrin Naz, Chetna Thawani, et al.
Pageof 7